| Pharmaceutical active ingredients: |
| Miglustat |
| Available forms, composition and doses of Zavesca: |
| Capsules; Oral; Miglustat 100 mg |
| Zavesca medical category: |
| Human:Glucosylceramide synthase inhibitorsType 1 Gaucher disease treatment drugs |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A16AX06 - Miglustat |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Actelion PharmaceuticalsTeva |
| Related documents and information about Zavesca: |
| Zavesca prescribing information (PDF) |